Multiple Sclerosis Program

More than 800 neurologist appointments were taken in 2012 at the Multiple Sclerosis (MS) Clinic, representing specialist care given to a substantial number of people who have multiple sclerosis. As the clinic continues to increase in popularity, two additional MS specialist neurologists were engaged in 2012 bringing the total number to seven, and the MS Fellowship was renewed.

In conjunction with the MS Clinic, researchers in the MS Clinical Trials Program continued to offer patients access to therapeutic trials of cutting edge therapies. Studies range from evaluating the safety, efficacy, and long-term impacts of new therapies on patients who have MS.

The team identified a number of clinical and MRI patterns that help distinguish non-MS inflammatory diseases from MS, facilitating prompt diagnosis and appropriate therapy. In 2012 recruitment began for a study to investigate the molecular events that underpin lesion development in MS, with the ultimate goal of improving disease monitoring and outcome.

The MS Laboratory Research Program is expected to move to the Brain and Mind Centre from the Camperdown Campus to facilitate the exchange in ideas and sharing of resources in multiple sclerosis clinical and laboratory research. In 2012, scientists in the MS Research Program completed a world-first proteomic analysis of MS brain tissue using techniques developed by the team in 2011.

Key Collaborators

  • Dr Ben Crossett, University of Sydney
  • Dr Linda Ly, University of Sydney
  • Professor John Prineas, University of Sydney
  • Professor John Pollard, Neuroinflammation Program, Brain and Mind Centre
  • Dr Judy Spies, Sydney Medical School
  • Multiple Sclerosis Research Australia
  • Royal Prince Alfred Hospital

Research facilities